Articles

EPIDEMIC ETHICS

Improving Trustworthiness in Global Health: Trustworthiness Talks

by Conrad Keating

As part of a listening and gathering process for the project ‘Improving Trustworthiness in Global Health’, Conrad Keating (Adjunct Professor and writer-in-residence at the School of Medicine, University College Dublin) ...

News

Announcing the Lassa Fever Vaccine Policy Research Agenda

The publication of the first-ever Lassa Fever Vaccine Policy Research Agenda is a landmark achievement for regional health security and vaccine preparedness in West Africa

It aims to guide researchers, funders, and policymakers in aligning ongoing and future studies with the most pressing policy needs. The agenda also aims to strengthen coordination and ensure that new evidence directly informs national and regional vaccine readiness decisions. Read more

CEPI launches a Call for Proposal for innovative analytical technologies to improve vaccine manufacturing speed and equitable access

Deadline for application: 1 May 2026. An application may be submitted at any time; the review process will involve quarterly reviews throughout the 12-month application period

CEPI has announced a funding opportunity to develop innovative analytical technologies for vaccines. The goal is to reduce vaccine development, manufacturing, and release times; lower costs, improve equitable deployment in Low to Middle-Income Countries, and enhance analytical insights for vaccines. Read more

CEPI has launched the Research Preparedness Program (RPP)

The RPP will support both advanced-stage clinical development of CEPI’s portfolio vaccines against priority diseases and the 100 Days Mission

The objective of the RPP is to leverage investments for advanced-stage clinical development of CEPI's portfolio vaccines and support countries in key regions to generate emergency evidence in future outbreaks Read more

SPEAC’s Active Safety Surveillance Dashboard

SPEAC launches a new interactive dashboard summarizing published literature on active safety surveillance in low- and middle-income countries

Developed from a systematic review of peer-reviewed studies, this platform allows users to explore findings by country, vaccine, drug, disease, surveillance method, participant group, and study year. The tool supports vaccine and drug developers, pharmacovigilance programs, and public health stakeholders ... Read more

Older News Here |